1672 — Ascletis Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- HK$19.61bn
- HK$17.44bn
- CNY2.03m
Annual cashflow statement for Ascletis Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -199 | -315 | -145 | -301 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 8.31 | 82.8 | -132 | -74.9 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.2 | 59.4 | 34.5 | 13.8 | -417 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -147 | -142 | -224 | -342 | -417 |
| Capital Expenditures | -7.2 | -14.4 | -19.2 | -2.15 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -267 | -1,283 | 249 | 981 | 662 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -274 | -1,297 | 229 | 979 | 662 |
| Financing Cash Flow Items | -0.125 | -0.157 | -0.144 | -0.244 | 345 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -31.1 | -1.42 | -81.5 | -104 | 345 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -483 | -1,324 | -73.7 | 534 | 579 |